US Stock MarketDetailed Quotes

Lexaria Bioscience (LEXX)

Watchlist

0.6744
-0.0186-2.68%

Close May 6 15:56 ET

0.6600
-0.0144-2.14%

Pre 04:05 ET

16.72MMarket Cap-1.43P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexaria Bioscience (LEXX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Feb 28, 2026

(Q1)Nov 30, 2025

(FY)Aug 31, 2025

(Q4)Aug 31, 2025

(Q3)May 31, 2025

(Q2)Feb 28, 2025

(Q1)Nov 30, 2024

(FY)Aug 31, 2024

(Q4)Aug 31, 2024

(Q3)May 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-44.46%-2.16M

63.90%-984.1K

-110.74%-10.45M

-39.69%-2.64M

-183.08%-3.58M

-141.75%-1.5M

-130.70%-2.73M

15.68%-4.96M

-16.65%-1.89M

29.11%-1.27M

Net income from continuing operations

46.53%-1.45M

40.98%-1.6M

-105.06%-11.91M

-23.35%-2.7M

-112.44%-3.79M

-316.25%-2.72M

-128.40%-2.71M

13.47%-5.81M

-75.06%-2.19M

25.14%-1.78M

Depreciation and amortization

738.87%19.1K

-49.19%16.87K

15.33%87.83K

30.71%21.4K

105.35%30.96K

-85.71%2.28K

15.35%33.2K

-47.62%76.15K

-76.92%16.37K

-39.73%15.07K

Other non cash items

0.01%9.27K

-0.01%9.27K

-5.60%37.07K

-3.89%9.27K

-0.79%9.27K

-49.37%9.27K

366.95%9.27K

-10.31%39.28K

-11.91%9.64K

-27.90%9.34K

Change In working capital

-178.25%-814.41K

376.64%490.28K

83.54%195.58K

-286.03%-323.93K

-550.82%-344.08K

11,231.73%1.04M

-31.72%-177.23K

-25.62%106.56K

124.36%174.13K

-84.10%76.32K

-Change in receivables

168.00%46.02K

356.10%280.31K

-323.83%-214.32K

-122.13%-10.23K

-121.65%-26.96K

-136.25%-67.67K

73.18%-109.45K

-290.54%-50.57K

1,660.55%46.21K

451.00%124.56K

-Change in inventory

----

--0

----

-Change in prepaid assets

196.42%391.74K

-65.45%256.92K

108.63%55.31K

61.75%-309.16K

123.98%27.04K

-202.09%-406.27K

79.43%743.7K

-2,238.35%-641.03K

-1,074.33%-808.27K

63.65%-112.75K

-Change in payables and accrued expense

-181.55%-1.24M

95.28%-37.61K

-52.01%396.64K

-99.49%4.79K

-555.73%-334.82K

3,591.70%1.52M

-465.66%-797.42K

833.95%826.47K

219.65%937.62K

-91.19%73.47K

-Change in other current liabilities

0.01%-9.34K

-2.77%-9.34K

-11.48%-37.09K

-46.06%-9.34K

-4.21%-9.34K

---9.34K

---9.09K

25.75%-33.27K

42.95%-6.39K

32.20%-8.96K

-Change in other working capital

----

-200.00%-4.96K

--1

--0

---4.96K

--4.96K

----

Cash from discontinued investing activities

Operating cash flow

-44.46%-2.16M

63.90%-984.1K

-110.74%-10.45M

-39.69%-2.64M

-183.08%-3.58M

-141.75%-1.5M

-130.70%-2.73M

15.68%-4.96M

-16.65%-1.89M

29.11%-1.27M

Investing cash flow

Cash flow from continuing investing activities

-93.26%-53.91K

86.51%-5.1K

-28.85%-243.02K

-126.88%-157.88K

11.63%-19.44K

51.05%-27.89K

5.55%-37.8K

-11.20%-188.61K

-1.68%-69.59K

34.61%-22K

Net PPE purchase and sale

-4,081,500.00%-40.82K

--0

42.70%-24.65K

100.00%-1

--1

---1

---24.65K

-27.46%-43.01K

---43.01K

--0

Net intangibles purchase and sale

45.89%-15.09K

61.25%-5.1K

48.41%-75.11K

45.02%-14.61K

11.63%-19.44K

51.06%-27.89K

67.12%-13.16K

-7.16%-145.59K

61.17%-26.57K

34.61%-22K

Net investment purchase and sale

----

---143.27K

----

--0

----

Cash from discontinued investing activities

Investing cash flow

-93.26%-53.91K

86.51%-5.1K

-28.85%-243.02K

-126.88%-157.88K

11.63%-19.44K

51.05%-27.89K

5.55%-37.8K

-11.20%-188.61K

-1.68%-69.59K

34.61%-22K

Financing cash flow

Cash flow from continuing financing activities

25,873.16%3.04M

-20.05%3.47M

-41.39%6.05M

-66.51%1.69M

-99.66%11.72K

138.84%4.35M

548.86%10.32M

194.67%5.04M

Net common stock issuance

25,873.16%3.04M

-20.05%3.47M

43.66%6.05M

--0

--1.69M

-99.60%11.72K

248.27%4.35M

164.74%4.21M

--0

Proceeds from stock option exercised by employees

----

--0

----

--0

--6.11M

--0

--5.04M

Cash from discontinued financing activities

Financing cash flow

25,873.16%3.04M

-20.05%3.47M

-41.39%6.05M

--0

-66.51%1.69M

-99.66%11.72K

138.84%4.35M

548.86%10.32M

--0

194.67%5.04M

Net cash flow

Beginning cash position

-47.00%4.28M

-72.27%1.8M

380.72%6.5M

-45.72%4.59M

37.48%6.47M

313.39%8.08M

380.72%6.5M

-76.74%1.35M

167.36%8.46M

43.80%4.71M

Current changes in cash

154.57%826.27K

57.12%2.48M

-189.93%-4.65M

-42.79%-2.8M

-150.98%-1.91M

-154.54%-1.51M

164.61%1.58M

215.84%5.17M

-8.25%-1.96M

3,570.48%3.75M

Effect of exchange rate changes

121.66%20.64K

-80.91%-5.74K

-154.94%-50.52K

423.80%10.74K

3,097.82%37.17K

-281.05%-95.26K

-172.62%-3.18K

---19.82K

--2.05K

---1.24K

End cash Position

-20.73%5.13M

-47.00%4.28M

-72.27%1.8M

-45.72%4.59M

37.48%6.47M

313.39%8.08M

380.72%6.5M

167.36%8.46M

Free cash flow

-45.48%-2.22M

64.21%-989.2K

-104.95%-10.55M

-35.48%-2.66M

-179.75%-3.6M

-125.51%-1.53M

-126.23%-2.76M

14.93%-5.15M

-16.04%-1.96M

29.21%-1.29M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Feb 28, 2026	(Q1)Nov 30, 2025	(FY)Aug 31, 2025	(Q4)Aug 31, 2025	(Q3)May 31, 2025	(Q2)Feb 28, 2025	(Q1)Nov 30, 2024	(FY)Aug 31, 2024	(Q4)Aug 31, 2024	(Q3)May 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-44.46%-2.16M	63.90%-984.1K	-110.74%-10.45M	-39.69%-2.64M	-183.08%-3.58M	-141.75%-1.5M	-130.70%-2.73M	15.68%-4.96M	-16.65%-1.89M	29.11%-1.27M
Net income from continuing operations	46.53%-1.45M	40.98%-1.6M	-105.06%-11.91M	-23.35%-2.7M	-112.44%-3.79M	-316.25%-2.72M	-128.40%-2.71M	13.47%-5.81M	-75.06%-2.19M	25.14%-1.78M
Depreciation and amortization	738.87%19.1K	-49.19%16.87K	15.33%87.83K	30.71%21.4K	105.35%30.96K	-85.71%2.28K	15.35%33.2K	-47.62%76.15K	-76.92%16.37K	-39.73%15.07K
Other non cash items	0.01%9.27K	-0.01%9.27K	-5.60%37.07K	-3.89%9.27K	-0.79%9.27K	-49.37%9.27K	366.95%9.27K	-10.31%39.28K	-11.91%9.64K	-27.90%9.34K
Change In working capital	-178.25%-814.41K	376.64%490.28K	83.54%195.58K	-286.03%-323.93K	-550.82%-344.08K	11,231.73%1.04M	-31.72%-177.23K	-25.62%106.56K	124.36%174.13K	-84.10%76.32K
-Change in receivables	168.00%46.02K	356.10%280.31K	-323.83%-214.32K	-122.13%-10.23K	-121.65%-26.96K	-136.25%-67.67K	73.18%-109.45K	-290.54%-50.57K	1,660.55%46.21K	451.00%124.56K
-Change in inventory	----	----	----	----	----	----	----	--0	--0	----
-Change in prepaid assets	196.42%391.74K	-65.45%256.92K	108.63%55.31K	61.75%-309.16K	123.98%27.04K	-202.09%-406.27K	79.43%743.7K	-2,238.35%-641.03K	-1,074.33%-808.27K	63.65%-112.75K
-Change in payables and accrued expense	-181.55%-1.24M	95.28%-37.61K	-52.01%396.64K	-99.49%4.79K	-555.73%-334.82K	3,591.70%1.52M	-465.66%-797.42K	833.95%826.47K	219.65%937.62K	-91.19%73.47K
-Change in other current liabilities	0.01%-9.34K	-2.77%-9.34K	-11.48%-37.09K	-46.06%-9.34K	-4.21%-9.34K	---9.34K	---9.09K	25.75%-33.27K	42.95%-6.39K	32.20%-8.96K
-Change in other working capital	----	----	-200.00%-4.96K	--1	--0	--0	---4.96K	--4.96K	----	----
Cash from discontinued investing activities
Operating cash flow	-44.46%-2.16M	63.90%-984.1K	-110.74%-10.45M	-39.69%-2.64M	-183.08%-3.58M	-141.75%-1.5M	-130.70%-2.73M	15.68%-4.96M	-16.65%-1.89M	29.11%-1.27M
Investing cash flow
Cash flow from continuing investing activities	-93.26%-53.91K	86.51%-5.1K	-28.85%-243.02K	-126.88%-157.88K	11.63%-19.44K	51.05%-27.89K	5.55%-37.8K	-11.20%-188.61K	-1.68%-69.59K	34.61%-22K
Net PPE purchase and sale	-4,081,500.00%-40.82K	--0	42.70%-24.65K	100.00%-1	--1	---1	---24.65K	-27.46%-43.01K	---43.01K	--0
Net intangibles purchase and sale	45.89%-15.09K	61.25%-5.1K	48.41%-75.11K	45.02%-14.61K	11.63%-19.44K	51.06%-27.89K	67.12%-13.16K	-7.16%-145.59K	61.17%-26.57K	34.61%-22K
Net investment purchase and sale	----	----	---143.27K	----	----	----	----	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-93.26%-53.91K	86.51%-5.1K	-28.85%-243.02K	-126.88%-157.88K	11.63%-19.44K	51.05%-27.89K	5.55%-37.8K	-11.20%-188.61K	-1.68%-69.59K	34.61%-22K
Financing cash flow
Cash flow from continuing financing activities	25,873.16%3.04M	-20.05%3.47M	-41.39%6.05M	0	-66.51%1.69M	-99.66%11.72K	138.84%4.35M	548.86%10.32M	0	194.67%5.04M
Net common stock issuance	25,873.16%3.04M	-20.05%3.47M	43.66%6.05M	--0	--1.69M	-99.60%11.72K	248.27%4.35M	164.74%4.21M	--0	--0
Proceeds from stock option exercised by employees	----	----	--0	--0	----	----	--0	--6.11M	--0	--5.04M
Cash from discontinued financing activities
Financing cash flow	25,873.16%3.04M	-20.05%3.47M	-41.39%6.05M	--0	-66.51%1.69M	-99.66%11.72K	138.84%4.35M	548.86%10.32M	--0	194.67%5.04M
Net cash flow
Beginning cash position	-47.00%4.28M	-72.27%1.8M	380.72%6.5M	-45.72%4.59M	37.48%6.47M	313.39%8.08M	380.72%6.5M	-76.74%1.35M	167.36%8.46M	43.80%4.71M
Current changes in cash	154.57%826.27K	57.12%2.48M	-189.93%-4.65M	-42.79%-2.8M	-150.98%-1.91M	-154.54%-1.51M	164.61%1.58M	215.84%5.17M	-8.25%-1.96M	3,570.48%3.75M
Effect of exchange rate changes	121.66%20.64K	-80.91%-5.74K	-154.94%-50.52K	423.80%10.74K	3,097.82%37.17K	-281.05%-95.26K	-172.62%-3.18K	---19.82K	--2.05K	---1.24K
End cash Position	-20.73%5.13M	-47.00%4.28M	-72.27%1.8M	-72.27%1.8M	-45.72%4.59M	37.48%6.47M	313.39%8.08M	380.72%6.5M	380.72%6.5M	167.36%8.46M
Free cash flow	-45.48%-2.22M	64.21%-989.2K	-104.95%-10.55M	-35.48%-2.66M	-179.75%-3.6M	-125.51%-1.53M	-126.23%-2.76M	14.93%-5.15M	-16.04%-1.96M	29.21%-1.29M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm